CheckMate 649 biomarker analyses of NIVO + IPI vs chemo for patients with GC/GEJC/EAC
CheckMate 649 biomarker analyses of NIVO + IPI vs chemo for patients with GC/GEJC/EAC
Initial results from a phase 1 dose escalation trial of E-602 shows efficacy in solid tumours
Does the mind matter in cancer? Experiences of Psycho-oncology from a tertiary cancer centre in South Asia
Challenge mission to improve access to quality cancer care
Choosing Wisely: An important step in the right direction
Cancer situation in Cambodia
VT3989 is safe and well tolerated in patients with advanced malignant mesothelioma and NF2m cancers
Childhood cancer: The surprising scientific facts
Current and future status of cancer care in Calmette Hospital
Choosing Wisely in medical oncology
To avoid unnecessary second surgery in differentiated thyroid cancer
Combination of camonsertib plus PARPi shows clinical activity in DDR-aberrant tumours